News

Filter

Current filters:

Mergers & Acquisitions

126 to 135 of 97192 results

Europe’s research and generic/biosimilar industries join forces against counterfeiting

Europe’s research and generic/biosimilar industries join forces against counterfeiting

09-12-2014

Trade groups the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European…

ESMEuropeGenericsMarkets & MarketingPharmaceutical

NICE now proposes to recommend Stelara for psoriatic arthritis

NICE now proposes to recommend Stelara for psoriatic arthritis

09-12-2014

UK health cost watchdog, the National Institute for Health and Care Excellence (NICE) has opened a consultation…

Anti-Arthritics/RheumaticsBiotechnologyInflammatory diseasesJanssenJohnson & JohnsonPricingRegulationStelaraUK

"My staff are involved in setting the global healthcare agenda:" interview with Parexel's Thomas Senderovitz

08-12-2014

With so many balls to juggle in the development pathway of a new drug, pharma companies looking for support…

InterviewsParexelParexelPharmaceuticalResearchThomas Senderovitz

Official: Merck & Co to acquire Cubist for $8.4 billion

Official: Merck & Co to acquire Cubist for $8.4 billion

08-12-2014

Confirming weekend speculation and rumors, US pharma giant Merck & Co this morning said it has entered…

Antibiotics and Infectious diseasesBiotechnologyCubicinCubist PharmaceuticalsMerck & CoMergers & AcquisitionsZerbaxa

FDA approves new indication for Amgen's Xgeva

FDA approves new indication for Amgen's Xgeva

08-12-2014

USA-based Amgen says the US Food and Drug Administration has approved a new indication for Xgeva (denosumab),…

AmgenBiotechnologyOncologyRare diseasesRegulationUSAXgeva

EFPIA responds to European Commission's patent settlement report with own transparency proposal

EFPIA responds to European Commission's patent settlement report with own transparency proposal

08-12-2014

The European Commission has published its fifth Monitoring Report of Patent Settlements in the pharma…

EuropeEuropean CommissionLegalPharmaceuticalRegulation

Roche's Gazyvaro and Bayer’s Adempas approved by Scottish Medicines Consortium

Roche's Gazyvaro and Bayer’s Adempas approved by Scottish Medicines Consortium

08-12-2014

The Scottish Medicines Consortium has decided to grant access to Gazyvaro (obinutuzumab), manufactured…

AdempasBayerCardio-vascularGazyvaroOncologyPharmaceuticalRegulationRoche

A top-20 pharma to utilize Xyntek-Antares serializing for China

A top-20 pharma to utilize Xyntek-Antares serializing for China

08-12-2014

A top 20 multi-national pharmaceutical research and manufacturer is utilizing the Xyntek-Antares solution…

ChinaPharmaceuticalProductionRegulationXyntek

126 to 135 of 97192 results

Back to top